1-18 of 18
Peilong Lai
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Azacitidine, Venetoclax Combined with Chidamide (ABC-14 Regimen) As an Induction Therapy for Newly Diagnosed AML: A Real-World Retrospective Analysis By the ABC-14 Collaboration Group

Jianyu Weng, Chengxin Deng, Zhenqian Huang, Yuming Zhang, Wang Ying, Minming Li, Ping Wu, Honghua He, Xu Ye, Yirong Jiang, Min Dong, Zhenfang Liu, Xiaoliang Li, Runhui Zheng, Maoquan Zou, Lie Lin, Ying Zhao, Xiangzhong Zhang, Shuqin Cheng, Ziwen Guo, Xuejie Jiang, Zhilun Li, Jiaqi Tan, Chengwei Luo Luo, Suijing Wu, Peilong Lai, Yangqiu Li, Xin Huang, Xin Du
Journal: Blood
Blood (2024) 144 (Supplement 1): 6014.
https://doi.org/10.1182/blood-2024-210211
Published: 2024
Journal Articles

Single-Cell Analysis Reveals Altered Tumor Microenvironments of Relapse/ Refractory and Remission-Associated Acute Myeloid Leukemia Treated By ABC-14 Regimen

Xin Huang, Minming Li, Ping Wu, Chengxin Deng, Zesheng Lu, Yulian Wang, Suxia Geng, Chengwei Luo Luo, Peilong Lai, Xin Du, Jianyu Weng
Journal: Blood
Blood (2024) 144 (Supplement 1): 5802.
https://doi.org/10.1182/blood-2024-204516
Published: 2024
Journal Articles

MRD-Driven Prophylactic or Pre-Emptive Intervention with Chidamide-Based Treatment for High-Risk AML Relapse Post-Transplantation: A Real-World Experience from a Chinese Single Center

Ping Wu, Wei Ling, Chengwei Luo Luo, Lisi Huang, Ruohao Xu, Xiaoling Liang, Jiaqi Tan, Jinghua Wang, Peilong Lai, Suijing Wu, Birong Li, Haijie Huang, Suxia Geng, Xin Du, Jianyu Weng
Journal: Blood
Blood (2024) 144 (Supplement 1): 1575.
https://doi.org/10.1182/blood-2024-210697
Published: 2024
Journal Articles

Treatment-Free Remission Era: BCR-ABL1 mRNA Transcript Level <5% at 3 Months Predicts 24-Month Deep Molecular Response and Better Survival

Lisi Huang, Suxia Geng, Yulian Wang, Zesheng Lu, Chengxin Deng, Xin Huang, Minming Li, Lingji Zeng, Qiong Luo, Peilong Lai, Xin Du, Jianyu Weng
Journal: Blood
Blood (2023) 142 (Supplement 1): 4545.
https://doi.org/10.1182/blood-2023-185222
Published: 2023
Journal Articles

Chidamide-Based Pre-Emptive Treatment for High-Risk AML Patients after Hematopoietic Stem Cell Transplantation: A Real-World Experience from Chinese Single-Center

Ping Wu, Wei Ling, Chengwei Luo, Xiaomei Chen, Lisi Huang, Jinghua Wang, Peilong Lai, Suijing Wu, Xin Du, Jianyu Weng
Journal: Blood
Blood (2023) 142 (Supplement 1): 2890.
https://doi.org/10.1182/blood-2023-187924
Published: 2023
Journal Articles

ABC Regimen (Azacitidine, Venetoclax and Chidamide) Is Comparable to the “3+7” Regimen in Newly Diagnosed AML: A Real-World Experience from South China

Jianyu Weng, Xin Huang, Ping Wu, Chengxin Deng, Minming Li, Xiaomei Chen, Chengwei Luo, Hui Zeng, Yuming Zhang, Caixia Wang, Tingfen Deng, Lie Lin, Zhenqian Huang, Bingyi Wu, Guozheng Wang, Runhui Zheng, Xu Ye, Peilong Lai, Yang Liang, Huo Tan, Yangqiu Li, Xin Du
Journal: Blood
Blood (2023) 142 (Supplement 1): 1522.
https://doi.org/10.1182/blood-2023-188196
Published: 2023
Journal Articles

Multi-Omics Reveals Azacitidine Partially Restores Hematopoiesis-Supportive Functions in Mesenchymal Stromal Cells from Patients with Chronic Myelomonocytic Leukemia

Ruohao Xu, Suxia Geng, Lingji Zeng, Chengxin Deng, Xin Huang, Minming Li, Ping Wu, Peilong Lai, Jianyu Weng, Xin Du
Journal: Blood
Blood (2023) 142 (Supplement 1): 3221.
https://doi.org/10.1182/blood-2023-189197
Published: 2023
Journal Articles

Compared the Effect of Mitroxantrone ( MA) with Idarubicine (IA) for Acute Myeloid Leukemia Induction Therapy

Peilong Lai, Mingyan Wu, Minming Li, Chengxin Deng, Zesheng Lu, Chenwei Luo, Xin Huang, Pengjun Liao, Lisi Huang, Ping Wu, Wang Yulian, Changchun Wan, Wei Ling, Liye Zhong, Suijing Wu, Xin Du, MD PhD, Jianyu Weng, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5229.
https://doi.org/10.1182/blood-2018-99-116234
Published: 2018
Journal Articles

Artesunate Attenuate Chronic Graft-Versus-Host Disease By Regulating Th17/Treg Balance

Chen Xiaomei, Jianyu Weng, MD, Peilong Lai, Xin Huang, Wang Yulian, Suxia Geng, Liyan Guo, Tian Huang, Lingji Zeng, Xin Du, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5680.
https://doi.org/10.1182/blood-2018-99-114556
Published: 2018
Journal Articles

Blocking Stat3 to Regulate the Balance of Th17/Treg in Cgvhd Therapy

Jianyu Weng, Xin Huang, Xiaomei Chen, Qiong Luo, Jianhua Su, Jiaqi Tong, Zhi Cao, Peilong Lai, Suijing Wu, Chengwei Luo, Wei Ling, Xin Du
Journal: Blood
Blood (2015) 126 (23): 5420.
https://doi.org/10.1182/blood.V126.23.5420.5420
Published: 2015
Journal Articles

Predictive Factors of Treatment Response to Hypomethylating Agents in Patients with Myelodysplastic Syndrome

Ping Wu, Xin Du, Jianyu Weng, Chengxin Deng, Suxia Geng, Zesheng Lu, Peilong Lai, Xin Huang, Chengwei Luo
Journal: Blood
Blood (2015) 126 (23): 5199.
https://doi.org/10.1182/blood.V126.23.5199.5199
Published: 2015
Journal Articles

The Expression of the Co-Inhibitory Molecule PD-1 and Its Ligand PD-L1 in Patients with MDS

Suxia Geng, Jianyu Weng, Xin Huang, Ping Wu, Chengxin Deng, Peilong Lai, Xin Du
Journal: Blood
Blood (2015) 126 (23): 5212.
https://doi.org/10.1182/blood.V126.23.5212.5212
Published: 2015
Journal Articles

Combination of Cladribine, Cytarabine and Topotecan (CLAT) for Relapsed or Refractory Acute Myeloid Leukemia

Xiaomei Chen, Jianyu Weng, Yulian Wang, Chengxin Deng, Chengwei Luo, Pengjun Liao, Minming Li, Xin Huang, Peilong Lai, Lisi Huang, Zhi Cao, Changchun Wan, Liye Zhong, Suijing Wu, Zesheng Lu, Xiaoli Zou, Xin Du
Journal: Blood
Blood (2015) 126 (23): 4897.
https://doi.org/10.1182/blood.V126.23.4897.4897
Published: 2015
Journal Articles

Comparison of the 5 Year Medical Outcome and Quality of Life of Patients with Chronic Myeloid Leukemia Treated with Imatinib or Allogeneic Transplant

Lisi Huang, Xin Du, Jianyu Weng, MD, Peilong Lai, Zesheng Lu, Ping Wu, Suijing Wu, PhD, Chengwei Luo, Xin Huang, Suxia Geng
Journal: Blood
Blood (2015) 126 (23): 2118.
https://doi.org/10.1182/blood.V126.23.2118.2118
Published: 2015
Journal Articles

CD8α + Jagged2 high CD11b high Regulatory Dendritic Cells Prevent Acute Gvhd

Jianyu Weng, M.D., Xin Huang, Ping Wu, Peilong Lai, Yueying Li, M.D., Lin Xu, M.D., Suxia Geng, Xin Du, MD
Journal: Blood
Blood (2013) 122 (21): 5428.
https://doi.org/10.1182/blood.V122.21.5428.5428
Published: 2013
Journal Articles

A New Murine Model Of Chronic Graft Versus Host Disease

Xin Huang, Jianyu Weng, M.D., Ping Wu, Jiaqi Tong, Peilong Lai, Suxia Geng, Xin Du, MD
Journal: Blood
Blood (2013) 122 (21): 5429.
https://doi.org/10.1182/blood.V122.21.5429.5429
Published: 2013
Journal Articles

Bortezomib Inhibit Acute Graft-Versus-Host Disease Via Shifting the Combination of T Cells Subpopulations

Jianyu Weng, Shaoze Lin, Peilong Lai, Meikun Lv, Xin Du, PhD, Wei Ling, Rong Guo, Chengwei Luo
Journal: Blood
Blood (2011) 118 (21): 4709.
https://doi.org/10.1182/blood.V118.21.4709.4709
Published: 2011
Journal Articles

Selective Targeting of B Cells with Mesenchymal Stromal Cells Treatment Is An Efficacious Strategy for Cutaneous Cgvhd,

Peilong Lai, Jianyu Weng, Chenwei Luo, Rong Guo, Zesheng Lu, Suxia Geng, Xin Du, PhD, Suijing Wu
Journal: Blood
Blood (2011) 118 (21): 4086.
https://doi.org/10.1182/blood.V118.21.4086.4086
Published: 2011